Trials / Completed
CompletedNCT04237467
Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Men
Novel Evaluations of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Men Compared to Age Group-Matched Transgender Women and Cisgender Adults
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 16 (actual)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This study will examine markers of vascular endothelial function (vascular health) and metabolic profiles in older versus younger transgender men (people who were assigned female at birth but whose gender identity is male). Data will also be compared to those from age group-matched transgender women and cisgender women and men.
Conditions
- Transgender
- Gender Identity
- Vascular Stiffness
- Vascular Inflammation
- Blood Pressure
- Lipid Disorder
- Appetitive Behavior
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | There was no intervention. |
Timeline
- Start date
- 2020-01-29
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2020-01-23
- Last updated
- 2024-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04237467. Inclusion in this directory is not an endorsement.